AcuityMD Highlights Data on Shift of Colorectal Procedures to Ambulatory Surgery Centers

According to a recent LinkedIn post from AcuityMD, the company is highlighting internal data on the accelerating shift of endoscopic colorectal procedures from hospitals to ambulatory surgery centers, or ASCs. The post suggests that ASCs now perform the majority of these procedures in the U.S., with volumes up about 50% since 2018 to an estimated 9 million procedures in 2024, and with ASC share ranging from roughly 40% in the Midwest to nearly 70% in the South.

The company’s LinkedIn post underscores that this site-of-care migration may have significant implications for MedTech commercial strategy, including physician targeting, facility prioritization, and reimbursement dynamics. For investors, the emphasis on ASC-focused analytics and trend detection could indicate a product positioning that aligns with evolving care delivery patterns, potentially enhancing AcuityMD’s value proposition to device manufacturers seeking more precise market insight.

The post also frames the data release in the context of Colorectal Cancer Awareness Month, implicitly tying procedure growth and screening awareness to increased demand for endoscopic interventions. If AcuityMD can leverage this kind of specialty-specific, regionalized data across other therapeutic areas, it may strengthen its role as an intelligence layer for MedTech companies navigating shifts away from hospital-centric volumes and toward outpatient and ASC settings.